Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects

Publication Date	August 2008
Publisher	Espicom
Product Type	Report
Pages	352
ISBN Number	not applicable
Product Code	ESP00558

Price

£1,495.00
approximately: $2,185 | €1,638

PDF

Order above formats by FAX

Summary

Over 350 information-packed pages providing
Forecasts of biomarker market value and therapy share to 2015
Detailed analysis of the products and potential of companies active in each sector

40 Cancer
29 CNS
34 Cardiovascular

Major biomarker approaches include

Proteomics
RNA & MicroRNA
DNA
Metabolic
Electrophysiology

Imaging By 2015, the biomarker market is forecast to be worth over US$20 billion as the cardiovascular and CNS biomarker market segments begin to mature with the launch of a number of diagnostic tests to guide the treatment of neuropsychiatric and neurodegenerative diseases.

This new 3-volume report provides a comprehensive analysis of the major therapy areas which are driving growth, along with a critical assessment of the companies involved.

Unique analysis and scoring

To provide commercial and industry managers with qualified insight to the corporate landscape, the report provides a unique assessment and scoring system for each company covering:

Biomarker technology
Association/clinical studies
Management strategy
Application & potential

Content

Executive Summary
- Figure1: Growth In Biomarker Market 2007-2015
What Are Biomarkers?
Why Are They Important?
- Figure 2: Potential Impact Of Biomarkers On Disease Pathways
What Technologies Are Involved?
What Impact Will Biomarkers Have On R&d?
- Figure 3: Potential Impact Of Biomarkers On R&d
Who Are The Major Biomarker Players And In What Research Area?
Cancer Biomarker Companies
Cardiovascular Biomarker Companies
Cns Biomarkers Companies
Company Analysis Criteria
Biomarker Technology & Platforms
Association/Clinical Studies
- Management Strategy
Application & Potential
Cancer Market & Revenues
- Market Revenues - Global
  - Figure 1: Global Cancer Drugs Sales (2007)
- Market Revenues Leading Brands
  - Figure 2: Leading Cancer Brands (2007)
- Market Revenues Leading Players
  - Figure 3: Top 10 Oncology Players (2007 Revenues)
- Cancer Epidemiology, Diagnosis, Screening & Treatment
- Epidemiology
  - Table 1: Cancer Statistics For Four Most Common Cancers, 2008
- Diagnosis
- Screening
  - Table 2: Cancer Screening
- Current & Future Treatment
- Future Treatment
  - Figure 4: Anticancer Drugs In Clinical Development
Cancer Biomarkers
- Cancer Biomarker R&d
  - Table 3: Types Of Biomarker
- Known Cancer Biomarkers
  - Table 4: Commercially Available Known Cancer Biomarker Diagnostics
- Probable And Possible Valid Cancer Biomarkers
  - Table 5: Probable Cancer Biomarkers Diagnostics
  - Table 6: Possible Cancer Biomarkers Diagnostics
- Cancer Biomarker Opportunities & Challenges
- Opportunities
- Challenges
Biomarker Market
- Biomarker Market Revenues - Global
  - Figure 8: Global Biomarker Sales In 2007
- Cancer Biomarker Market Revenues - Global
  - Figure 9: Global Cancer Biomarker Sales In 2007
- Section Name Cancer, Cns & Cardiovascular Biomarkers: Players, Products And Prospects
- Future Biomarker Market Revenues Global
  - Figure 10: Global Biomarker Sales In 2015
- Future Cancer Biomarker Market Revenues - Global
  - Figure 11: Global Cancer Biomarker Sales In 2015
Cancer Biomarker Trends
- Table 7: Recent Deals In Oncology Biomarkers
Pharma And Specialty Pharma Deals
Collaborations With Service Providers
Collaborations With Academics And Consortia
Biomarker Analysis
Dna Biomarkers
Rna And Microrna Biomarkers
Proteomic Biomarkers
Key Biomarker Companies Analysed
Key Biomarker Evaluation Criteria
Cancer Biomarker- Company Analysis
Abbott Diagnostics
- Biomarker Novelty & Technology Platform
- Figure 12: Abbotts Urovysion Bladder Cancer Test
- Association Studies/Clinical Data
- Pivotal Trial
- Table 7: Comparison Of Urovysion Vs Cystoscopy/Histology For Detection Of Bladder Cancer Recurrence By Stage And Grade*
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Affymetrix
- Biomarker Novelty & Technology Platform
- Figure 13: Affymetrix Approach To Biomarker Discovery, Validation And Clinical Utility Applications
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Agendia Bv
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Figure 14: Mammaprint Profile Vs Nih Consensus Criteria
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Altheadx
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Aveo Pharmaceuticals
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
- Cancer, Cns & Cardiovascular Biomarkers: Players, Products And Prospects Section Name
Aviaradx
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Bg Medicine
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Figure 15: Bg Medicines Biomarker Programme
- Application & Market Potential
- Biomarker Analysis
Beckman Coulter
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Biocurex
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Biomedical Diagnostics
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Biomerica
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Bruker Daltonics
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Caprion Proteomics
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
- Clinical Data
- Biomarker Novelty & Technology Platform
- Section Name Cancer, Cns & Cardiovascular Biomarkers: Players, Products And Prospects
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Celera
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Dako Denmark A/S
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Dxs Ltd
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Epigenomics Ag
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Epistem Plc
- Biomarker Novelty & Technology Platform
- Figure 16: Epistems Biomarker Drug Development Programme
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Genenews
- Biomarker Novelty & Technology Platform
- Figure 17: Genenews Sentinel Principle
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Fujirebio Diagnostics, Inc
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Genomic Health
- Biomarker Novelty & Technology Platform
- Figure 18: Oncotype Dx Test For Invasive Breast Cancer
- Cancer, Cns & Cardiovascular Biomarkers: Players, Products And Prospects Section Name
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Gen-Probe
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Genzyme Genetics
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Intergenetics
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Ipsogen Therapeutics
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Figure 19: Oncotype Dx Test For Invasive Breast Cancer
- Application & Market Potential
- Biomarker Analysis
Laboratory Corporation Of America
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Matritech
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Monogram Biosciences
- Biomarker Novelty & Technology Platform
- Figure 20: Veratag Assay
- Association Studies/Clinical Data
- Figure 21: Veratag Clinical Data: Bordet Cohort
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Orion Genomics
- Biomarker Novelty & Technology Platform
- Section Name Cancer, Cns & Cardiovascular Biomarkers: Players, Products And Prospects
- Figure 22: Orions Methylscope
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Oxford Genome Biosciences (Uk) Ltd
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Power3 Medical Products
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Figure 23: Powder3s Business Strategy
- Application & Market Potential
- Biomarker Analysis
Predictive Biosciences
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Provista Life Sciences
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Quest Diagnostics
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Roche Diagnostics
- Biomarker Novelty & Technology Platform
- Figure 24: Diagnostic Marker Candidate To A Product
- Association Studies/Clinical Data
- Figure 25: Biomarkers Distinguish Leukaemia Subclasses
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Superarray Bioscience Corporation
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Third Wave Technologies
- Cancer, Cns & Cardiovascular Biomarkers: Players, Products And Prospects Section Name
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Upstream Biosciences
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Veridex, Llc
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Vermillion
- Biomarker Novelty & Technology Platform
- Association Studies/Clinical Data
- Management Strategy
- Application & Market Potential
- Biomarker Analysis
Cancer Biomarker Appendix 1
- Table 8: Global Biomarker Sales 2007-20015e
Cancer Biomarker Appendix 2
- Table 8: Global Cancer Biomarker Sales 2007-20015e
Cancer Biomarker Appendix 3
Company Analysis Criteria
Biomarker Technology & Platforms
Association Studies
- Management Strategy
Application & Potential
- Table 9: Key Cancer Biomarker Companies
- Figure 26: Leading Cancer Biomarker Companies Service Providers, Technology Providers, Biomarker Discovery & Diagnostic Developers
Glossary
Acronyms
Bibliography & End Notes
Cns Market & Revenues
- Market Revenues - Global
  - Figure 1: Global Cns Drugs Sales (2007)
- Market Revenues Leading Brands
  - Figure 2: Leading Cns Brands (2007)
- Market Revenues Leading Players
  - Figure 3: Top 10 Cns Players (2007 Revenues)
Cns Epidemiology, Diagnosis, Screening & Treatment
- Epidemiology
  - Table 1: Cns Statistics For The Most Common Cns Disorders, 2008
- Diagnosis
  - Table 2: Indication For Ct And Mri In The Cns
- Screening
- Section Name Cancer, Cns & Cardiovascular Biomarkers: Players, Products And Prospects
- Current & Future Treatment
  - Table 3: Classes Of Cns Drugs Approved For Acute And Chronic Conditions
- Future Treatment
  - Figure 4: Cns Drugs In Clinical Development
Cns Biomarkers
Cns Biomarker R&d
- Figure 5: Imaging Biomarkers As Surrogate Endpoints
- Table 4: Types Of Biomarker